SCHEMBL6826899

SCHEMBL6826899

CC(C)c1c(N)ccc2c1c1ccccc1n2C(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 5/20 0.48
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
UTS2R Q9UKP6 1/20 0.41
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
ATM Q13315 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
DHFR P00374 2/20 0.36
SLC2A1 P11166 1/20 0.36
POLB P06746 2/20 0.35
HTT P42858 1/20 0.35
PRKD3 O94806 1/20 0.35
PRKCG P05129 1/20 0.35
PRKCB P05771 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6823801 0.83 NPY5R (0.47) NPY5RMEN1KMT2AUTS2RBCHE
SCHEMBL6826569 0.76 KMT2A (0.56) NPY5RMEN1KMT2AUTS2RBCHE
SCHEMBL16696085 0.73 TSHR (0.46) NPY5RMEN1KMT2AUTS2RBCHE
SCHEMBL25702400 0.73 GPR3 (0.52) NPY5RMEN1KMT2AUTS2RBCHE
SCHEMBL150044 0.73 BCHE (0.59) NPY5RMEN1KMT2AUTS2RBCHE
SCHEMBL29780042 0.73 BCHE (0.59) NPY5RMEN1KMT2AUTS2RBCHE
SCHEMBL26237869 0.73 UTS2R (0.50) NPY5RMEN1KMT2AUTS2RBCHE
SCHEMBL20096984 0.71 UTS2R (0.46) NPY5RMEN1KMT2AUTS2RBCHE
SCHEMBL17833734 0.71 POLB (0.48) NPY5RMEN1KMT2AUTS2RBCHE
SCHEMBL24264458 0.70 POLB (0.47) NPY5RMEN1KMT2AUTS2RBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1531527-A Carbazole derivatives and their use as neuropeptide Y5 receptor ligands 2004-09-22 CN disclosed
US-20040067999-A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands ASTRAZENECA AB (SE) 2004-04-08 US disclosed
EP-1358157-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS AstraZeneca AB (SE) 2003-11-05 EP disclosed
WO-2002051806-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2002-07-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067999-A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands NPY5R, NPY1R, NPY2R NPY5R 1/4885MEN1 767/4885KMT2A 3618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.